Exercise program for breast cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of a novel exercise intervention specifically designed for breast cancer survivors who have completed their treatment. It aims to assess how rowing as a form of cardiovascular rehabilitation can reduce the risk of cardiovascular disease in this population. Participants will engage in structured exercise training to evaluate improvements in their cardiovascular health. The study focuses on women aged 40 to 80 who have been cancer-free for 6 to 24 months after treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* diagnosis of primary invasive non-metastatic breast cancer, stages I-III
* female based on biological sex
* 40 to 80 years of age
* completed breast cancer treatment 6 to 24 months prior to study enrollment. Adjuvant endocrine therapy for breast cancer (e.g., ovarian suppression, SERMs, SERDs, AIs), CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy and bisphosphonates are allowed within 6 months prior to study enrollment and during study participation
* absence of contraindications to exercise or study participation
* study clinician approval

Exclusion Criteria:

* do not meet inclusion criteria
* receiving or scheduled to receive treatment for breast cancer (i.e., chemotherapy, surgery, or radiation) during study participation is not allowed. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy and bisphosphonates are allowed during study participation
* lymphedema stage ≥ 2 prior to study enrolment
* any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)
* current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)
* consistent participation in ≥150 min/week of moderate-intensity rowing exercise training in previous 6 months

Where it's running

• Integrative Cardiovasculal Physiology Laboratory, University of Florida
  Gainesville, Florida, United States Recruiting

Study contacts

• Principal investigator: Demetra Christou, PhD — University of Florida
• Study coordinator: Demetra Christou, PhD
• Email: ddchristou@ufl.edu
• Phone: 352-294-1746

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exergames-acceptance and Commitment Therapy for Breast Cancer Depression and Anxiety

  This trial tests whether a combined exergame-based program with acceptance and commitment therapy helps reduce depression and anxiety in breast cancer survivors compared with ACT alone or standard care.

  Recruiting Universiti Sains Malaysia · Xinxiang, Henan · NCT07721753

• Polarized light therapy to reduce radiation dermatitis in breast cancer patients

  Aly randomized trial will test whether adding polarized light therapy to standard skin care can lessen radiation dermatitis in women receiving hypofractionated whole-breast radiotherapy.

  Recruiting Beni-Suef University · Banī Suwayf · NCT07600957

• Home-based ear vagus nerve stimulation for breast cancer pain and symptoms

  This trial will test whether a handheld at-home transcutaneous auricular vagus nerve stimulation (taVNS) device can reduce pain and other symptoms in breast cancer survivors with ongoing moderate pain.

  Recruiting Florida State University · Tallahassee, Florida · NCT07500012

• Electroacupuncture vs. Ear Acupressure for Breast Cancer–Related Joint Pain

  This trial tests whether electroacupuncture or ear acupressure can lessen joint pain caused by endocrine therapy in breast cancer survivors compared with a waitlist control.

  Recruiting at 6 sites First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Wuhan, Hubei and 5 other locations · NCT07490938

• How short aerobic workouts affect tumor cells in breast cancer survivors

  This will test whether a single session of moderate or high intensity aerobic exercise changes circulating myokines and tumor cell responses in premenopausal women who survived stage II–III triple‑negative breast cancer compared with matched healthy women.

  Recruiting Riga Stradins University · Riga, Dzirciema Street 16 · NCT07439458

• Real-world use of EndoPredict to guide treatment in early HR+/HER2- breast cancer

  This tests whether the EndoPredict genomic test can predict 10-year relapse risk and help decide if people with early HR+/HER2- breast cancer need chemotherapy in addition to hormone therapy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07379918

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.